In case you hadn’t heard, the US Supreme Court chose not to address the FDA’s over-relaxation of regulations regarding the abortion pill by declaring that the plaintiffs lacked standing (see more at LifeSiteNews).
It seems like such a waste to spend all the time and money to get a case to the Supreme Court just to find out they won’t address it!
However, perhaps not all that effort is lost. There is still the possibility of getting the Court to take notice “for another challenger who can show a direct injury from Mifepristone traceable to the FDA’s deregulation.”
Discover more from Pikes Peak Citizens for Life
Subscribe to get the latest posts sent to your email.